Inpharma Weekly

, Volume 1632, Issue 1, pp 26–26 | Cite as

EU Commission refers lapatinib back to CHMP.

Media release

Keywords

Breast Cancer Marketing Medium Release Lapatinib Oral Treatment 

Copyright information

© Adis International Ltd 2008

Personalised recommendations